Retraction: At diabetes-like concentration, glucose down-regulates the placental serotonin transport system in a cell-cycle-dependent manner (Journal of Neurochemistry, (2007), 101, 4, (937-948), 10.1111/j.1471-4159.2007.04469.x);At diabetes-like concentration, glucose down-regulates the placental serotonin transport system in a cell-cycle-dependent manner

Journal of Neurochemistry

Volumn 101, Issue 4, 2007, Pages 937-948

  Unal, R ^a   Ahmed, B A ^a   Jeffus, B C ^a   Harney, J T ^a   Lyle, C S ^a   Wu, Y K ^a   Chambers, T C ^a   Reece, E A ^a   Kilic, F ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

5HT transporter; In vitro diabetic model; Placenta; Serotonin uptake

Indexed keywords

GLUCOSE; OLIGOMER; SEROTONIN; SEROTONIN TRANSPORTER;

ARTICLE; CELL CULTURE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL MEMBRANE; CHORIOCARCINOMA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PLACENTA CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SEROTONINERGIC SYSTEM;

EID: 34247623166     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.14931     Document Type: Erratum

References (39)

1. Balkovetz D. F., Tiruppathi C., Leibach F. H., Mahesh V. B. Ganapathy V. (1989) Evidence for an imipramine-sensitive serotonin transporter in human placental brush-border membranes. J. Biol. Chem. 264, 2195 2198.
2. Bengel, D., Murphy, D. L., Andrews, A. M., Wichems, C. H., Feltner, D., Heils, A., Mossner, R., Westphal, H. Lesch, K. (1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine (''Ecstasy'') in serotonin transporter-deficient mice. Mol. Pharmacol. 53, 649 655.
3. Blakely, R. D., Berson, H. E., Fremeau, R.T. Jr., Caron, M. C., Peek, M. M. Priace, H. K. Bradley, C. C. (1991) Cloning and expression of a functional serotonin transporter from rat brain. Nature 354, 66 70.
4. Brownlee M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813 820.
5. Cases O, Vitalis T, Seif I, De Maeyer E, Sotelo C Gaspar P. (1996) Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron 16, 297 307.
6. Dunphy W. G., Brizuela L., Beach D. Newport J. (1988) The Xenopus cdc2 protein is a component of MPF, a cytoplasmic regulator of mitosis. Cell 54, 423 431.
7. Fukumoto T., Blakely R. Levin M. (2005) Serotonin transporter function is an early step in left-right patterning in chick and frog embryos. Dev. Neurosci. 27, 349 363.
8. Ganapathy V. Leibach F. H. (1995) Placental biogenic amines and their transporters, in Placental Toxicology (Ramasaastry B. V. ed.), pp. 161 174. CRC Press, Boca Raton.
9. Ganapathy V. Leibach F. H. (1994) Human placenta: a direct target for cocaine action. Placenta 15, 785 795.
10. Greenberg B. D., Tolliver T. J., Huang S-J., Li Q., Bengel D. Murphy D. L. (1999) Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am. J. Med. Genet. 88, 83 87.
11. Hahn T., Barth S., Weiss U., Mosgoeller W. Desoye G. (1998) Sustained hyperglycemia in vitro down-regulates the GLUT1 glucose transport system of cultured human term placental trophoblast: a mechanism to protect fetal development FASEB J. 12, 1221 1231.
12. Hansson S. R. Mezey E. Hoffman B. J. (1999) Serotonin transporter messenger RNA expression in neural crest-derived structures and sensory pathways of the developing rat embryo. Neuroscience 89, 243 265.
13. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D. Lesch K. P. (1996) Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66, 2621 2624.
14. Hendricks T. J., Fyodorov D. V., Wegman L. J., Lelutiu N. B., Pehek E. A., Yamamoto B., Silver J., Weeber E. J., Sweatt J.D. Deneris E. S. (2003) Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron 37, 233 247.
15. Hendricks T., Francis N., Fyodorov D. Deneris E. S. (1999) The ETS domain factor Pet-1 is an early and precise marker of central serotonin neurons and interacts with a conserved element in serotonergic genes. J. Neuroscience 19, 10348 10356.
16. Kekuda R., Leibach F. H., Furesz T. C., Smith C. H. Ganapathy V. (2000) "Polarized distribution of interleukin-1 receptors and their role in regulation of serotonin transporter in placenta. J. Pharmacol. Exp. Ther. 292, 1032 41.
17. Kilic F. Rudnick G. (2000) Oligomerization of 5HT transporter and its functional consequences. Proc. Natl. Acad. Sci. USA 97, 3106 3111.
18. Kilic F., Murphy D. Rudnick G. (2003) A Human 5HT transporter mutation causes constitutive activation of transport activity. Mol. Pharmacol. 64, 4 12.
19. Kocabas A., Rudnick G. Kilic F. (2003) Functional consequences of Homo- But Not Hetero-Oligomerization between transporters for the biogenic amine neurotransmitters. J. Neurochem. 85, 1513 1520.
20. Lauder J. M., Tamir H. Sadler T. W. (1988) Serotonin and morphogenesis. I. Sites of serotonin uptake and -binding protein immunoreactivity in the midgestation mouse embryo. Development 102, 709 720.
21. Lauder J. M. (1993) Neurotransmitters as growth regulatory signals: role of receptors and second messengers. Trends Neurosci. 16, 233 240.
22. Lesch K. P., Bengel D., Heils A., Sabol S. Z., Greenberg B. D., Petri S., Benjamin J., Muller C. R., Hamer D. H. Murphy D. L. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527 1531.
23. Liu J. P. Lauder J. M. (1992) S-100 beta and insulin-like growth factor-II differentially regulate growth of developing serotonin and dopamine neurons in vitro. J. Neurosci. Res. 33, 248 256.
24. McGeer P. L. McGeer E. G. (1973) Neurotransmitter synthetic enzymes. Prog. Neurobiol. 2, 69 117.
25. Ogura K., Sakata M., Yamaguchi M., Kurachi H. Murata Y. (1999) High concentration of glucose decreases glucose transporter-1 expression in mouse placenta in vitro and in vivo. J. Endocrinol. 160, 443 452.
26. Ozaslan D., Wang S., Ahmed B., Bene A., Kocabas A. M. Kilic F. (2003) Glycosyl modification facilitates homo- and hetero-oligomerization of serotonin transporter. A specific role for the sialic acid residues. J. Biol. Chem. 278, 43991 44000.
27. Prasad P. D., Leibach F. H., Mahesh V. B., Ganapathy V. (1994) Human placenta as a target organ for cocaine action: interaction of cocaine with the placental serotonin transporter. Placenta 15, 267 278.
28. Ramamoorthy S., Baumen A. L., Moore K. R., Han H., Yang-Fen T., Chang A. S., Ganapathy V. Blakely R. D. (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc. Natl. Acad. Sci. USA 90, 2542 2546.
29. Ramamoorthy J. D., Ramamoorthy S., Leibach F. H. Ganapathy V. (1995) Antidepressant- and cocaine-sensitive human the 5HT transporter: molecular cloning, expression, and chromosomal localization. Am. J. Obstet. Gynecol. 173, 1782 1787.
30. Renold A. E., Stauffacher W. Cahill G. F. (1977) Diabetes Mellitus, in The Metabolic Basis of Inherited Disease Stanbury J. B., Wyngaarden J. B. Fredricson D. S. eds McGraw-Hill, New York.
31. Salichon N., Gaspar P., Upton A. L., Picaud S., Hanoun N., Hamon M., De Maeyer E., Murphy D. L, Mossner R., Lesch K. P., Hen R. Seif I. (2001) Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. J. Neurosci. 21, 884 896.
32. Schmid J. A., Scholze P., Kudlacek O., Freissmuth M., Singer E. A. Sitte H. H. (2001) Oligomerization of the human 5HT transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells. J. Biol. Chem. 276, 3805 3810.
33. Smith C. H., Moe A. J. Ganapathy V. (1992) Nutrient transport pathways across the epithelium of the placenta. Annu. Rev. Nutr. 12, 183 206.
34. Swenne I. (1990) Islet cell thymidine kinase activity as indicator of islet cell proliferation in rat pancreas. Diabetes 39, 70 5.
35. Vitalis T., Cases O., Callebert J., Launay J. M., Price D. J., Seif I. Gaspar P. (1998) Effects of monoamine oxidase A inhibition on barrel formation in the mouse somatosensory cortex: determination of a sensitive developmental period. J. Comp. Neurol. 393, 169 184.
36. Wall S. C., Innis R. B. Rudnick G. (1993) Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding. Mol. Pharmacol. 43, 264 270.
37. Walther D. J. Bader M. (1999) Serotonin synthesis in murine embryonic stem cells. Mol. Brain Res. 68, 55 63.
38. Weiss U., Cervar M., Puerstner P., Schmut O., Haas J., Mauschitz R., Arikan G. Desoye G. (2001) Hyperglycemia in vitro alters the proliferation and mitochondrial activity of the choriocarcinoma cell lines BeWo, JAR and JEG-3 as models for human first-trimester trophoblast. Diabetologia 44, 209 219.
39. Ye W., Shimamura K., Rubenstein J. L., Hynes M. A. Rosenthal A. (1998) FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 93, 755 766.